A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model
- PMID: 35355758
- PMCID: PMC8934106
- DOI: 10.22092/ari.2021.356004.1762
A Novel Phage Cocktail Therapy of the Urinary Tract Infection in a Mouse Model
Abstract
Escherichia coli (E. coli) is a major bacterial pathogen associated with many cases of serious infections, such as urinary tract infections (UTI) and meningitis intestinal. The rapid emergence of antimicrobial multidrug-resistant bacteria occurring worldwide has been attributed to the overuse of antibiotics. Alternative strategies must be developed to overcome antibiotic resistance. A promising alternative for the treatment of infections is the use of phages as antibacterial agents. A total of 90 female albino mice were randomly divided into three groups (n=30) and used for the induction of UTI. The animals were acclimatized in their cages for 24 h before inoculation and allowed to access chow and water freely. For UTI induction, the peri-urethral area was sterilized with 70% ethanol, and bacterial inoculation was then injected into the bladder through the urethra using a 24-gauge sterile Teflon catheter with an outer diameter of 0.7 mm and length of 19 mm. A single phage and a phage cocktail preparation have been evaluated for their therapeutic activity in the mouse model of chronic UTI induced by transurethral injection of two isolates of the uropathogenic E. coli 8 and E. coli 302. The results of the transurethral and intra-peritoneal injection of phage(s) that prepared on day 10 after the establishment of the mouse chronic model showed no effect of a single phage PEC80 in the treatment of UTI, whereas both administration routes of the phage cocktail preparation resulted in the clearance of bacteria from mice urine and homogenates of the urinary bladders and kidneys of the sacrificed mice after 24 h following the administration of phage cocktail dose. The high activity of the phage cocktail in the treatment of mouse chronic model of UTI is attributed to the broader host range of the phage cocktail, compared to the very narrow host range of the phage PEC80. It is concluded that the phage therapy by using phage preparations as the 25 phages cocktail evaluated in this study is a highly promising and potential alternative therapy for human UTIs.
Keywords: Alternative Therapy; Drug Resistance; Phage Cocktail; Phage Therapy; UTI.
Figures








Similar articles
-
Bacteriophage therapy for Escherichia coli-induced urinary tract infection in rats.Future Microbiol. 2023 Apr;18:323-334. doi: 10.2217/fmb-2022-0107. Epub 2023 May 4. Future Microbiol. 2023. PMID: 37140267
-
Rapid formulation of a genetically diverse phage cocktail targeting uropathogenic Escherichia coli infections using the UTI89 model.Sci Rep. 2025 Apr 14;15(1):12832. doi: 10.1038/s41598-025-96561-y. Sci Rep. 2025. PMID: 40229393 Free PMC article.
-
Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.mSphere. 2022 Aug 31;7(4):e0034522. doi: 10.1128/msphere.00345-22. Epub 2022 Aug 3. mSphere. 2022. PMID: 35920561 Free PMC article.
-
Bacteriophage therapy for inhibition of multi drug-resistant uropathogenic bacteria: a narrative review.Ann Clin Microbiol Antimicrob. 2021 Apr 26;20(1):30. doi: 10.1186/s12941-021-00433-y. Ann Clin Microbiol Antimicrob. 2021. PMID: 33902597 Free PMC article. Review.
-
The rise, fall, and resurgence of phage therapy for urinary tract infection.EcoSal Plus. 2024 Dec 12;12(1):eesp00292023. doi: 10.1128/ecosalplus.esp-0029-2023. Epub 2024 Jan 11. EcoSal Plus. 2024. PMID: 39665540 Free PMC article. Review.
Cited by
-
Isolation, characterization and liposome-loaded encapsulation of a novel virulent Salmonella phage vB-SeS-01.Front Microbiol. 2025 Jan 24;16:1494647. doi: 10.3389/fmicb.2025.1494647. eCollection 2025. Front Microbiol. 2025. PMID: 39927265 Free PMC article.
-
Characterization and Comparative Genomics Analysis of a New Bacteriophage BUCT610 against Klebsiella pneumoniae and Efficacy Assessment in Galleria mellonella Larvae.Int J Mol Sci. 2022 Jul 21;23(14):8040. doi: 10.3390/ijms23148040. Int J Mol Sci. 2022. PMID: 35887393 Free PMC article.
-
Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment.Microorganisms. 2023 Aug 28;11(9):2169. doi: 10.3390/microorganisms11092169. Microorganisms. 2023. PMID: 37764013 Free PMC article. Review.
-
Potential of phage depolymerase for the treatment of bacterial biofilms.Virulence. 2023 Dec;14(1):2273567. doi: 10.1080/21505594.2023.2273567. Epub 2023 Oct 31. Virulence. 2023. PMID: 37872768 Free PMC article. Review.
-
Phage Therapy in the Management of Urinary Tract Infections: A Comprehensive Systematic Review.Phage (New Rochelle). 2023 Sep 1;4(3):112-127. doi: 10.1089/phage.2023.0024. Epub 2023 Sep 20. Phage (New Rochelle). 2023. PMID: 37771568 Free PMC article.
References
-
- Chanishvili N. A literature review of the practical application of bacteriophage research. Lit Rev Pract App Bacteriophage Res. 2012:1–292.
-
- Kaabi S, Ali B. Development of phage cocktail against extensive drug and pandrug resistant Escherichia coli causing urinary tract infection: an invitro study. Cell Arch. 2020;20:3709–14.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical